Cargando…

Decreased NAD+ in dopaminergic neurons

Detalles Bibliográficos
Autores principales:	Sison, Samantha L., Ebert, Allison D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940114/ https://www.ncbi.nlm.nih.gov/pubmed/29706611 http://dx.doi.org/10.18632/aging.101433

Ejemplares similares

Decreased Sirtuin Deacetylase Activity in LRRK2 G2019S iPSC-Derived Dopaminergic Neurons
por: Schwab, Andrew J., et al.
Publicado: (2017)

Modeling Protein Aggregation and the Heat Shock Response in ALS iPSC-Derived Motor Neurons
por: Seminary, Emily R., et al.
Publicado: (2018)

Crosstalk of parkin and Ret in dopaminergic neurons
por: Kramer, Edgar R.
Publicado: (2015)

Dopaminergic neurons: linking longevity with reproduction?
por: Tian, Xiaolin
Publicado: (2022)

Oncogene-induced NAD(+) depletion in tumorigenesis
por: Tummala, Krishna S., et al.
Publicado: (2015)

Bacteria boost host NAD metabolism
por: Shats, Igor, et al.
Publicado: (2020)

NAD(+) to assess health in aging humans
por: Janssens, Georges E., et al.
Publicado: (2022)

NAD+ Precursors: A Physiological Reboot?
por: Niño-Narvión, Julia, et al.
Publicado: (2023)

Elevated mitochondria-coupled NAD(P)H in endoplasmic reticulum of dopamine neurons
por: Tucker, Kristal R., et al.
Publicado: (2016)

PARPs, PAR and NAD Metabolism and Their Inhibitors in Cancer
por: Curtin, Nicola, et al.
Publicado: (2020)

NAD(+) deficit, protein acetylation and muscle aging
por: Ji, Li Li, et al.
Publicado: (2021)

NAD(+) oscillation and hypothalamic neuronal functions
por: Tokizane, Kyohei, et al.
Publicado: (2021)

Targeting on the NAD(+)‐mitophagy axis to treat cardiovascular disease
por: Fang, Evandro F., et al.
Publicado: (2020)

Decreased dopaminergic inhibition of pyramidal neurons in anterior cingulate cortex maintains chronic neuropathic pain
por: Lançon, Kevin, et al.
Publicado: (2021)

Disinhibition Bursting of Dopaminergic Neurons
por: Lobb, Collin J., et al.
Publicado: (2011)

Parkinson's disease and dopaminergic neurons
Publicado: (2012)

CD38-NAD(+)-Sirt1 axis in T cell immunotherapy
por: Chatterjee, Shilpak, et al.
Publicado: (2019)

The NAD(+) precursor nicotinamide riboside decreases exercise performance in rats
por: Kourtzidis, Ioannis A., et al.
Publicado: (2016)

Proliferation and Differentiation of Dopaminergic Neurons from Human Neuroepithelial Stem Cells Obtained from Embryo Reduction Following In Vitro Fertilization
por: Binh, Nguyen Thi, et al.
Publicado: (2021)

Destruction of Dopaminergic Neurons in the Midbrain by 6-Hydroxydopamine Decreases Hippocampal Cell Proliferation in Rats: Reversal by Fluoxetine
por: Suzuki, Katsuaki, et al.
Publicado: (2010)

Effects of NAD(+) in Caenorhabditis elegans Models of Neuronal Damage
por: Lee, Yuri, et al.
Publicado: (2020)

IGF2 prevents dopaminergic neuronal loss and decreases intracellular alpha-synuclein accumulation in Parkinson’s disease models
por: Arcos, Javiera, et al.
Publicado: (2023)

Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
por: Mamelak, Mortimer
Publicado: (2018)

Necrostatin-1 protection of dopaminergic neurons
por: Wu, Jing-ru, et al.
Publicado: (2015)

Acquisition of the Midbrain Dopaminergic Neuronal Identity
por: Mesman, Simone, et al.
Publicado: (2020)

A decrease in NAD(+) contributes to the loss of osteoprogenitors and bone mass with aging
por: Kim, Ha-Neui, et al.
Publicado: (2021)

Integrin α5β1 expression on dopaminergic neurons is involved in dopaminergic neurite outgrowth on striatal neurons
por: Izumi, Yasuhiko, et al.
Publicado: (2017)

MPP(+) decreases store-operated calcium entry and TRPC1 expression in Mesenchymal Stem Cell derived dopaminergic neurons
por: Sun, Yuyang, et al.
Publicado: (2018)

Pedunculopontine glutamatergic neurons control spike patterning in substantia nigra dopaminergic neurons
por: Galtieri, Daniel J, et al.
Publicado: (2017)

Sequential Loss of LC Noradrenergic and Dopaminergic Neurons Results in a Correlation of Dopaminergic Neuronal Number to Striatal Dopamine Concentration
por: Szot, Patricia, et al.
Publicado: (2012)

Spread of neuronal degeneration in a dopaminergic, Lrrk-G2019S model of Parkinson disease
por: Hindle, Samantha J., et al.
Publicado: (2013)

Silencing of Syntaxin 1A in the Dopaminergic Neurons Decreases the Activity of the Dopamine Transporter and Prevents Amphetamine-Induced Behaviors in C. elegans
por: Lanzo, Ambra, et al.
Publicado: (2018)

Dichotomous Dopaminergic Control of Ventral Pallidum Neurons
por: Clark, Martin, et al.
Publicado: (2018)

Gene regulatory logic of dopaminergic neuron differentiation
por: Flames, Nuria, et al.
Publicado: (2009)

Vulnerability of Mesostriatal Dopaminergic Neurons in Parkinson's Disease
por: González-Hernández, Tomás, et al.
Publicado: (2010)

An effective inducer of dopaminergic neuron-like differentiation
por: Fu, Wenyu, et al.
Publicado: (2013)

The Role of Dopaminergic VTA Neurons in General Anesthesia
por: Zhou, Xuelong, et al.
Publicado: (2015)

Molecular Programming of Mesodiencephalic Dopaminergic Neuronal Subsets
por: Smidt, Marten P.
Publicado: (2017)

An optimized method for counting dopaminergic neurons in zebrafish
por: Matsui, Hideaki, et al.
Publicado: (2017)

Adolescent Intermittent Ethanol Exposure Is Associated with Increased Risky Choice and Decreased Dopaminergic and Cholinergic Neuron Markers in Adult Rats
por: Boutros, Nathalie, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_cmk1o9p0i8k1smdjpk3e9skqtj